FindTrial
Sign In

Survival status of Chinese patients with esophageal cancer after radiotherapy

Survival status of Chinese patients with esophageal cancer after radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054266
Enrollment
Unknown
Registered
2021-12-12
Start date
2015-01-01
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

case series:None

Sponsors

National Cancer Center / Chinese Academy of Medical Sciences and Peking Union Medical College Cancer Hospital Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with esophageal cancer who were treated with radical radiotherapy (radiotherapy dose >=50 Gy) from 2015 to 2016; 2. Aged >= 18 years; 3. The radiation field is the primary esophageal tumor with or without lymph node metastasis.

Exclusion criteria

Exclusion criteria: 1. Palliative radiotherapy; 2. The radiotherapy site is the metastatic foci such as bone brain, adrenal gland, isolated metastatic lymph node and other sites.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Quality of life;Financial burden;Medical care services;Psychological survey;—

Countries

China

Contacts

Public ContactWang Luhua
wlhwq@yahoo.com+86 13601283715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026